Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- MEL-SELFIndependent statistical analysis of Patient-led Surveillance Compared to Clinician-led Surveillance in People Treated for Localised Melanoma.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Mel47Independent statistical analysis of Temsirolimus and Bevacizumab in Treating Patients With Stage III or Stage IV Malignant Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Mel55Independent statistical analysis of Study to Assess Safety and Immune Response of Stage IIB-IV Resected Melanoma After Treatment With MAGE-A3 ASCI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Mel62; 6PACIndependent statistical analysis of A Phase I/II Trial to Evaluate a Peptide Vaccine Plus Ipilimumab in Patients With Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Mel64Independent statistical analysis of Safety Study of a Helper Peptide Vaccine Plus Pembrolizumab: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02515227).
- MelaOstrongIndependent statistical analysis of Melatonin and Osteogenic Loading on Osteopenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04233112).
- Melatonin for Circadian Sleep Disorders in the Blind: Complete Statistical AnalysisIndependent statistical analysis of Melatonin for Circadian Sleep Disorders in the Blind: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00911053).
- Melatonin in Smoke-induced Vascular Injury: Complete Statistical AnalysisIndependent statistical analysis of Melatonin in Smoke-induced Vascular Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02591238).
- Melatonin Intervention For Neurocognitive Deficits in the St. Jude Lifetime Cohort: Complete Statistical AnalysisIndependent statistical analysis of Melatonin Intervention For Neurocognitive Deficits in the St. Jude Lifetime Cohort: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Melatonin Postoperative Sleep Study in Breast Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of Melatonin Postoperative Sleep Study in Breast Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00506064).
- Melatonin Supplementation for Cancer-related Fatigue in Patients Receiving Radiotherapy: Complete Statistical AnalysisIndependent statistical analysis of Melatonin Supplementation for Cancer-related Fatigue in Patients Receiving Radiotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02332928).
- Melatonin Versus Placebo in Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Melatonin Versus Placebo in Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01805089).
- Melphalan and Bortezomib Prior to Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of Melphalan and Bortezomib Prior to Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Melphalan and Panobinostat (LBH589) for the Treatment of Patients With Recurrent Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of Melphalan and Panobinostat (LBH589) for the Treatment of Patients With Recurrent Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- MELTEMIIndependent statistical analysis of A Safety Extension Study With Benralizumab for Asthmatic Adults on Inhaled Corticosteroid Plus Long-acting β2 Agonist: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Memantine Augmentation of Lamotrigine Incomplete-Response in Bipolar Depression: Complete Statistical AnalysisIndependent statistical analysis of Memantine Augmentation of Lamotrigine Incomplete-Response in Bipolar Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00305578).
- Memantine Effects on Sensorimotor Gating and Neurocognition in Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of Memantine Effects on Sensorimotor Gating and Neurocognition in Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03860597).
- Memantine for Executive Dysfunction in Adults With ADHD: A Pilot Study: Complete Statistical AnalysisIndependent statistical analysis of Memantine for Executive Dysfunction in Adults With ADHD: A Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Memantine-enhanced Buprenorphine Treatment for Opioid-dependent Young Adults: Complete Statistical AnalysisIndependent statistical analysis of Memantine-enhanced Buprenorphine Treatment for Opioid-dependent Young Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01052662).
- MEMOIndependent statistical analysis of Safety and Efficacy of Sequential Therapy With Mexidol® in Patients With Chronic Cerebral Ischemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Memory and Attention Adaptation Training-Geriatrics (MAAT-G): Complete Statistical AnalysisIndependent statistical analysis of Memory and Attention Adaptation Training-Geriatrics (MAAT-G): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04230941).
- Men Together Making a Difference: Reducing HIV/STD Risk Behavior Among South African Men: Complete Statistical AnalysisIndependent statistical analysis of Men Together Making a Difference: Reducing HIV/STD Risk Behavior Among South African Men: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- MENDEL-2Independent statistical analysis of Monoclonal Antibody Against PCSK9 to Reduce Elevated LDL-C in Subjects Currently Not Receiving Drug Therapy for Easing Lipid Levels-2: primary endpoint results, effect estimate with confidence interval, sample-size…
- Meningeal Inflammation on 7T MRI as a Tool for Measuring and Predicting Ocrelizumab Response in Multiple Sclerosis: Complete Statistical AnalysisIndependent statistical analysis of Meningeal Inflammation on 7T MRI as a Tool for Measuring and Predicting Ocrelizumab Response in Multiple Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Menopausal Sleep Fragmentation and Body Fat Gain: Complete Statistical AnalysisIndependent statistical analysis of Menopausal Sleep Fragmentation and Body Fat Gain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03047330).
- Menopur® Versus Follistim® in Polycystic Ovarian Syndrome (PCOS): Complete Statistical AnalysisIndependent statistical analysis of Menopur® Versus Follistim® in Polycystic Ovarian Syndrome (PCOS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00805935).
- Mental Health Support for Transgender and Gender-expansive Individuals: Complete Statistical AnalysisIndependent statistical analysis of Mental Health Support for Transgender and Gender-expansive Individuals: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06229132).
- Mental Imagery Therapy for Autism (MITA) – an Early Intervention Computerized Language Training Program for Children With ASD: Complete Statistical AnalysisIndependent statistical analysis of Mental Imagery Therapy for Autism (MITA) - an Early Intervention Computerized Language Training Program for Children With ASD: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Mental Stress Reduction in Defibrillator Patients: Complete Statistical AnalysisIndependent statistical analysis of Mental Stress Reduction in Defibrillator Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00624520).
- Menthol Flavored E-cigarette Use During a Simulated Ban of Menthol Cigarettes: Complete Statistical AnalysisIndependent statistical analysis of Menthol Flavored E-cigarette Use During a Simulated Ban of Menthol Cigarettes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Mepolizumab in Chronic Obstructive Pulmonary Diseases (COPD) With Eosinophilic Bronchitis: Complete Statistical AnalysisIndependent statistical analysis of Mepolizumab in Chronic Obstructive Pulmonary Diseases (COPD) With Eosinophilic Bronchitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01463644).
- MEQIndependent statistical analysis of Study of the Validity of Using the MEQ to Measure Mindful Eating in Pregnant Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- MERCURIndependent statistical analysis of A Study of Subcutaneous Mircera in Participants With Chronic Kidney Disease Not Treated With ESA or on Dialysis: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- MERITIndependent statistical analysis of A Study of Erlotinib (Tarceva) in Participants With Non-Small Cell Lung Cancer (NSCLC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- MERITIndependent statistical analysis of Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02623426).
- Merits of Performing a Modified Template Retroperitoneal Lymph Node Dissection: Complete Statistical AnalysisIndependent statistical analysis of Merits of Performing a Modified Template Retroperitoneal Lymph Node Dissection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00751140).
- MERLINIndependent statistical analysis of A Trial of Bardoxolone Methyl in Patients With CKD at Risk of Rapid Progression (MERLIN): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- MERLOTIndependent statistical analysis of Macular EpiRetinal Brachytherapy Versus Lucentis® Only Treatment (MERLOT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01006538).
- MERMAIDIndependent statistical analysis of Merotocin in Mothers With Inadequate Milk Production and Infants Delivered Prematurely: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- MERMAID-1Independent statistical analysis of Phase III Study to Determine the Efficacy of Durvalumab in Combination With Chemotherapy in Completely Resected Stage II-III Non-small Cell Lung Cancer (NSCLC): primary endpoint results, effect estimate…
- Mesalamine 4 g Sachet for the Induction of Remission in Active, Mild to Moderate Ulcerative Colitis (UC): Complete Statistical AnalysisIndependent statistical analysis of Mesalamine 4 g Sachet for the Induction of Remission in Active, Mild to Moderate Ulcerative Colitis (UC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Mesalamine to Reduce T Cell Activation in HIV Infection: Complete Statistical AnalysisIndependent statistical analysis of Mesalamine to Reduce T Cell Activation in HIV Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01090102).
- MESHIndependent statistical analysis of Mobile Evidence-Based Smoking Cessation for Veterans Living With HIV (MESH): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04135937).
- Mesothelin-Targeted Immunotoxin LMB-100 Alone or in Combination With Nab-Paclitaxel in People With Previously Treated Metastatic and/or Locally Advanced Pancreatic Ductal Adenocarcinoma and Mesothelin Expressing Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of Mesothelin-Targeted Immunotoxin LMB-100 Alone or in Combination With Nab-Paclitaxel in People With Previously Treated Metastatic and/or Locally Advanced Pancreatic Ductal Adenocarcinoma and Mesothelin Expressing Solid Tumors: primary endpoint…
- Mesothelin-Targeted Immunotoxin LMB-100 in Combination With SEL-110 in Subjects With Malignant Pleural or Peritoneal Mesothelioma: Complete Statistical AnalysisIndependent statistical analysis of Mesothelin-Targeted Immunotoxin LMB-100 in Combination With SEL-110 in Subjects With Malignant Pleural or Peritoneal Mesothelioma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- MESRIXIndependent statistical analysis of Mesenchymal Stemcells for Radiation Induced Xerostomia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02513238).
- Messages About Reduced Nicotine in Combusted Tobacco Products: Complete Statistical AnalysisIndependent statistical analysis of Messages About Reduced Nicotine in Combusted Tobacco Products: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05506046).
- Messenger RNA (mRNA)-Based, Personalized Cancer Vaccine Against Neoantigens Expressed by the Autologous Cancer: Complete Statistical AnalysisIndependent statistical analysis of Messenger RNA (mRNA)-Based, Personalized Cancer Vaccine Against Neoantigens Expressed by the Autologous Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Messy Memories: Mobile Application Therapy Following Critical Illness: Complete Statistical AnalysisIndependent statistical analysis of Messy Memories: Mobile Application Therapy Following Critical Illness: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05849454).
- MESTRE-MSIndependent statistical analysis of MEasuring Satisfaction of Treatment With REbif After Initial Treatment of Multiple Sclerosis (MS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…